Recently, it was shown that cyclin-dependent kinase 5 (CDK5)-mediated phosphorylation of PPARγ may be involved in the pathogenesis of insulin resistance and glucose-lowering effects, which provides a new angle to understand the mechanisms of PPARγ activation27. The gene discussed is CDK5; the disease is Insulin resistance.